One of the main challenges is the dual role of autophagy in cancer. While autophagy can prevent the initiation of cancer by removing damaged cells, it can also support cancer cell survival under stress conditions like hypoxia and chemotherapy. Thus, modulating Beclin 1 activity requires a nuanced approach to ensure it benefits the patient.
